ITUB Itau posts Q4 2025 EPS miss even as shares edge higher on steady investor sentiment Allogene ALLO Stock Is It Worth Buying Q4 2025 EPS Tops Views SPXC SPX Technologies falls 231 after narrow Q4 2025 EPS miss trails analyst consensus estimates Bluejay Diag BJDX Innovation Pipeline Q4 2023 Profit Disappoints Johnson Johnson JNJ Gains From CoPartnered HIV Portfolio Performance In GSKs Strong Q1 2026 Earnings Beat ACHC AcadiaHealth delivers 182 percent Q4 2025 EPS surprise shares gain 247 percent amid upbeat investor sentiment FLD Fold Holdings posts far wider than expected Q4 2025 loss shares stay flat with no reported quarterly revenue Is Adamas Trust ADAMI stock overvalued CHT Chunghwa Tel falls 138 after Q4 2025 EPS narrowly misses consensus analyst estimates